# Bronchial Hyper-responsiveness in Reflux Cough

> **NCT00668317** · PHASE3 · TERMINATED · sponsor: **Hull University Teaching Hospitals NHS Trust** · enrollment: 5 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** Omeprazole
- **DRUG:** Ranitidine

## Key facts

- **NCT ID:** NCT00668317
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2009-09
- **Final completion:** 2010-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Primary care physicians began prescribing antacid therapy for chronic cough
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668317, "Bronchial Hyper-responsiveness in Reflux Cough". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00668317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*